Los Angeles Capital Management LLC Acquires 10,116 Shares of Sabra Healthcare REIT, Inc. $SBRA

Los Angeles Capital Management LLC boosted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 16.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,455 shares of the real estate investment trust’s stock after buying an additional 10,116 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Sabra Healthcare REIT were worth $1,336,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. SVB Wealth LLC bought a new stake in Sabra Healthcare REIT during the 1st quarter valued at $34,000. Wealth Preservation Advisors LLC bought a new position in shares of Sabra Healthcare REIT in the 1st quarter worth $38,000. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Sabra Healthcare REIT by 61.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after purchasing an additional 1,065 shares during the last quarter. Anchor Investment Management LLC bought a new stake in Sabra Healthcare REIT during the first quarter valued at about $58,000. Finally, Assetmark Inc. boosted its position in Sabra Healthcare REIT by 37.8% during the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust’s stock valued at $63,000 after purchasing an additional 989 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Analyst Ratings Changes

SBRA has been the subject of a number of recent research reports. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price for the company. Wells Fargo & Company cut their price objective on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. BMO Capital Markets boosted their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research note on Monday, August 25th. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Finally, Truist Financial lifted their price target on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a report on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.75.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock opened at $18.88 on Thursday. The firm has a market capitalization of $4.71 billion, a P/E ratio of 24.84, a PEG ratio of 1.10 and a beta of 0.84. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a 50 day moving average price of $18.40 and a 200 day moving average price of $18.30. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $190.04 million during the quarter, compared to analysts’ expectations of $193.44 million. During the same period last year, the business earned $0.37 EPS. Sabra Healthcare REIT’s revenue for the quarter was up 6.7% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 28th. Stockholders of record on Monday, November 17th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Monday, November 17th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. Sabra Healthcare REIT’s payout ratio is 166.67%.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.